United Capital Financial Advisers, LLC Biogen Inc. Transaction History

United Capital Financial Advisers, LLC

  • $11.7 Billion
  • Q4 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Biogen Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 4,874 shares of BIIB stock, worth $700,734. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,874
Previous 87,375 94.42%
Holding current value
$700,734
Previous $16.9 Million 95.6%
% of portfolio
0.01%
Previous 0.09%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$146.47 - $191.55 $12.1 Million - $15.8 Million
-82,501 Reduced 94.42%
4,874 $745,000
Q3 2024

Nov 12, 2024
SELL
$189.07 - $236.8 $340,893 - $426,950
-1,803 Reduced 2.02%
87,375 $16.9 Million
Q2 2024

Aug 14, 2024
SELL
$190.52 - $236.72 $418,762 - $520,310
-2,198 Reduced 2.41%
89,178 $20.7 Million
Q1 2024

May 15, 2024
SELL
$212.02 - $267.71 $825,605 - $1.04 Million
-3,894 Reduced 4.09%
91,376 $19.7 Million
Q4 2023

Feb 14, 2024
SELL
$222.59 - $267.94 $15.7 Million - $18.9 Million
-70,369 Reduced 42.48%
95,270 $24.7 Million
Q3 2023

Nov 14, 2023
SELL
$253.3 - $285.89 $5.36 Million - $6.05 Million
-21,170 Reduced 11.33%
165,639 $42.6 Million
Q2 2023

Aug 14, 2023
SELL
$275.25 - $318.06 $761,616 - $880,072
-2,767 Reduced 1.46%
186,809 $53.2 Million
Q1 2023

Aug 14, 2023
BUY
$256.56 - $292.34 $709,901 - $808,904
2,767 Added 1.48%
189,576 $52.7 Million
Q1 2023

May 15, 2023
SELL
$256.56 - $292.34 $605,994 - $690,507
-2,362 Reduced 1.23%
189,576 $52.7 Million
Q4 2022

Feb 14, 2023
SELL
$252.44 - $306.72 $2.42 Million - $2.94 Million
-9,592 Reduced 4.76%
191,938 $53.2 Million
Q3 2022

Nov 14, 2022
SELL
$194.69 - $268.46 $239,663 - $330,474
-1,231 Reduced 0.61%
201,530 $53.8 Million
Q2 2022

Aug 11, 2022
BUY
$187.54 - $223.02 $551,742 - $656,124
2,942 Added 1.47%
202,761 $41.4 Million
Q1 2022

May 16, 2022
BUY
$193.77 - $244.14 $7.68 Million - $9.68 Million
39,640 Added 24.75%
199,819 $42.1 Million
Q4 2021

Feb 14, 2022
BUY
$223.92 - $287.77 $792,228 - $1.02 Million
3,538 Added 2.26%
160,179 $38.4 Million
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $919,151 - $1.2 Million
3,248 Added 2.12%
156,641 $44.3 Million
Q2 2021

Aug 13, 2021
BUY
$259.0 - $414.71 $310,023 - $496,407
1,197 Added 0.79%
153,393 $53.1 Million
Q1 2021

May 14, 2021
BUY
$242.95 - $284.63 $5.2 Million - $6.09 Million
21,407 Added 16.37%
152,196 $42.6 Million
Q4 2020

Feb 17, 2021
BUY
$236.26 - $355.63 $846,519 - $1.27 Million
3,583 Added 2.82%
130,789 $32 Million
Q3 2020

Nov 13, 2020
BUY
$264.77 - $305.71 $2.55 Million - $2.94 Million
9,617 Added 8.18%
127,206 $36.1 Million
Q2 2020

Aug 13, 2020
BUY
$258.66 - $342.55 $3.61 Million - $4.78 Million
13,943 Added 13.45%
117,589 $31.5 Million
Q1 2020

May 15, 2020
SELL
$268.85 - $341.04 $946,083 - $1.2 Million
-3,519 Reduced 3.28%
103,646 $31.6 Million
Q4 2019

Feb 14, 2020
BUY
$220.06 - $304.07 $1.68 Million - $2.33 Million
7,654 Added 7.69%
107,165 $31.8 Million
Q3 2019

Nov 14, 2019
BUY
$217.44 - $243.88 $983,481 - $1.1 Million
4,523 Added 4.76%
99,511 $23.2 Million
Q2 2019

Aug 13, 2019
BUY
$219.29 - $241.72 $5.78 Million - $6.37 Million
26,360 Added 38.41%
94,988 $22.2 Million
Q1 2019

May 14, 2019
BUY
$216.71 - $338.96 $1.12 Million - $1.74 Million
5,146 Added 8.11%
68,628 $16.2 Million
Q4 2018

Feb 14, 2019
BUY
$278.5 - $352.75 $1.58 Million - $2 Million
5,680 Added 9.83%
63,482 $19.1 Million
Q3 2018

Nov 14, 2018
BUY
$293.51 - $383.83 $600,227 - $784,932
2,045 Added 3.67%
57,802 $20.4 Million
Q2 2018

Aug 14, 2018
BUY
$257.52 - $306.91 $663,371 - $790,600
2,576 Added 4.84%
55,757 $16.2 Million
Q1 2018

May 15, 2018
BUY
$260.13 - $367.91 $740,590 - $1.05 Million
2,847 Added 5.66%
53,181 $14.6 Million
Q4 2017

Feb 13, 2018
BUY
$307.64 - $344.58 $796,787 - $892,462
2,590 Added 5.42%
50,334 $16.1 Million
Q3 2017

Nov 14, 2017
BUY
$281.15 - $329.69 $771,194 - $904,339
2,743 Added 6.1%
47,744 $15 Million
Q2 2017

Aug 14, 2017
BUY
N/A
45,001
45,001 $12.2 Million

Others Institutions Holding BIIB

# of Institutions
1,001
Shares Held
131M
Call Options Held
1.77M
Put Options Held
2.34M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email